a proposed clinical advantage of cmt over conventional tetracyclines , in the treatment of diseases characterized by excessive collagenolytic activity , is the lack of development of antibiotic-resistant micro-organisms during prolonged use .
C0039644
cmt
C0039651
tetracyclines